MCM
ELV icon

MidAtlantic Capital Management’s Elevance Health ELV Stock Holding History

MidAtlantic Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40
Closed -$14K – 122
2025
Q4 		$14K Buy
+40
New +$13.5K 0.01% 197
2025
Q1 		– Sell
-40
Closed -$14.8K – 121
2024
Q4 		$14.8K Hold
40
– – 0.01% 194
2024
Q3 		$20.8K Hold
40
– – 0.02% 175
2024
Q2 		$21.7K Hold
40
– – 0.02% 162
2024
Q1 		$20.7K Hold
40
– – 0.02% 172
2023
Q4 		$18.9K Buy
+40
New +$18.5K 0.02% 175

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

MidAtlantic Capital Management's ELV Position: Q1 2026 in Review

MidAtlantic Capital Management sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 40 shares — an estimated $14K sold.

MidAtlantic Capital Management first reported a position in ELV in Q4 2023 and held it in 6 quarters. The position peaked at $21.7K in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • MidAtlantic Capital Management reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • MidAtlantic Capital Management sold 40 Elevance Health shares in Q1 2026, an estimated $14K.
  • MidAtlantic Capital Management first reported a position in Elevance Health in Q4 2023 and held it in 6 quarters.
  • MidAtlantic Capital Management's Elevance Health position peaked at $21.7K in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on MidAtlantic Capital Management's 13F filing for Q1 2026, filed 8 May 2026.